TCL Archive New Phase III Follow-Up Data of Yervoy Trial Shows 19 Percent Survival at Four Years October 26, 2012
TCL Archive NCI To Invite Unaffiliated Oncologists To Enroll Patients On Phase III Trials May 10, 2002